Genocea Biosciences (GNCA) PT Lowered to $9 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts GNCA Hot Sheet
Price: $0.05 --0%
Rating Summary:
9 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 15 | New: 42
Rating Summary:
9 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 15 | New: 42
Join SI Premium – FREE
H.C. Wainwright analyst Joseph Pantginis lowered the price target on Genocea Biosciences (NASDAQ: GNCA) to $9.00 (from $32.00) while maintaining a Buy rating.
You May Also Be Interested In
- Stryker (SYK) PT Lowered to $330 at Stifel
- IQVIA Holdings (IQV) PT Raised to $319 at RBC Capital
- Neurocrine Bio. (NBIX) PT Lowered to $214 at UBS, Buy Rating Maintained
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
